Document is current
Any future updates will be listed below
-
Authors
Masson, Walter https://orcid.org/0000-0002-5620-6468
Lobo, Martín
Nogueira, Juan P.
Barbagelata, Leandro
Touzas, Pedro
Frías, Juan P.
- License Information
-
More Information
Article History
Accepted: 12 August 2025
First Online: 1 October 2025
Declarations
:
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
: WM and ML have served as a speaker from Novo Nordisk. JPF has the following disclosures: Research support (Akero, Altimmune, Boehringer Ingelheim, 89bio, Eli Lilly, Janssen, Madrigal, Merck, NorthSea Therapeutics, Novartis, Novo Nordisk, Oramed, Pfizer, Sanofi, and Shionogi), advisory boards and consulting (Akero, Altimmune, Boehringer Ingelheim, 89bio, Eli Lilly, Gilead, Intercept, Merck, Novo Nordisk, Pfizer, Sanofi), speaker bureau (Eli Lilly), and employee and stockholder (Biomea Fusion, Inc.). The rest of the authors have no conflicts to declare. The relationships disclosed by the authors did not influence the design, conduct, or interpretation of the data presented in this study.
